CMS(00867),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

00867 CMS

Market Closed 05-22 16:08:22

10.990

+0.010

+0.09%

High11.250	Low10.870	Vol3.05M
Open11.250	D1 Closing10.980	Amplitude3.46%
Mkt Cap26.82B	Tradable Cap26.81B	Total Shares2.44B
T/O33.54M	T/O Rate0.12%	Tradable Shares2.44B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"00867","market":"HK","secType":"STK","nameCN":"CMS","latestPrice":10.99,"timestamp":1779437302002,"preClose":10.98,"halted":0,"volume":3048507,"delay":0,"changeRate":0.0009107468123861372,"floatShares":2439528512,"shares":2440000000,"eps":0.6154,"marketStatus":"Market Closed","change":0.01,"latestTime":"05-22 16:08:22","open":11.25,"high":11.25,"low":10.87,"amount":33544562,"amplitude":0.034608,"askPrice":11,"askSize":9000,"bidPrice":10.98,"bidSize":8000,"shortable":3,"etf":0,"ttmEps":0.684786,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779759000000},"marketStatusCode":7,"adr":0,"listingDate":1285603200000,"exchange":"SEHK","adjPreClose":10.98,"dividendRate":0.030631,"openAndCloseTimeList":[[1779413400000,1779422400000],[1779426000000,1779436800000]],"volumeRatio":0.7202867682133574,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00867","defaultTab":"news","newsList":[{"id":"1100932510","title":"AI Frenzy Shifts from Hardware to Applications, Musk-Related Concepts Gain Traction","url":"https://stock-news.laohu8.com/highlight/detail?id=1100932510","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100932510?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:13","pubTimestamp":1778155986,"startTime":"0","endTime":"0","summary":"The U.S. stock market saw the S&P 500 and Nasdaq indices hit new highs overnight due to continuous positive signals, which naturally influenced domestic markets. Hong Kong stocks opened higher today,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","CHAT","BK1583","IE00BVYPNP33.GBP","BK1515","00867","BK1191","LU2097828805.USD","IE00BGHQDM52.EUR","ARTY","LU2097828474.EUR","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","LU2097828631.EUR","IE00BYV24P56.USD","03933","SG9999004220.SGD","LU1969619763.USD","SG9999015986.USD","LU2097828557.USD","BK1161","SG9999015952.SGD","LU2242644610.SGD","DXYZ","BK1589","BK1521","IE00BZ08YS42.EUR","LU2097828714.EUR","AIPO","LU2488822045.USD","BK4588","IE00BVYPNQ40.USD","01177","AGIX","SG9999015978.USD","VXUS","LU0455707207.USD","BK1593","LU2328871848.SGD","BK4585","SG9999015945.SGD","01801","LU0502904849.HKD","IE00BMCWC346.EUR","UFO","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630398212","title":"CMS (867.HK/8a8.SG) Signed an Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer® and Cosmofer®","url":"https://stock-news.laohu8.com/highlight/detail?id=2630398212","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630398212?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:03","pubTimestamp":1777287832,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA2GKH6N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BGHQDM52.EUR","BK1191","SG9999015978.USD","SG9999015986.USD","SG9999004220.SGD","SG9999015952.SGD","LU2488822045.USD","IE00BYV24P56.USD","00867","SG9999015945.SGD","IE00BMCWC346.EUR","BK1593","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630398024","title":"China Medical System Holdings - Pharmacosmos to Manufacture and Supply Monofer and Cosmofer for Fifteen Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2630398024","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630398024?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:03","pubTimestamp":1777287832,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA2GKH6N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BYV24P56.USD","BK1191","IE00BVYPNP33.GBP","IE00BMCWC346.EUR","SG9999015986.USD","00867","SG9999015945.SGD","SG9999015978.USD","BK1593","LU2488822045.USD","IE00BVYPNQ40.USD","SG9999015952.SGD","IE00BGHQDM52.EUR","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629834706","title":"China Medical System Holdings: Nda for Mg-K10 for Seasonal Allergic Rhinitis Accepted by Nmpa in China on April 23, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629834706","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629834706?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:00","pubTimestamp":1776949254,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nFWN4160GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BGHQDM52.EUR","BK1593","LU2488822045.USD","SG9999004220.SGD","IE00BVYPNQ40.USD","IE00BYV24P56.USD","SG9999015986.USD","SG9999015952.SGD","SG9999015945.SGD","IE00BVYPNP33.GBP","SG9999015978.USD","IE00BMCWC346.EUR","00867","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161816734","title":"CMS Secures NMPA Nod to Review MG-K10 NDA for Once-Monthly Treatment of Seasonal Allergic Rhinitis","url":"https://stock-news.laohu8.com/highlight/detail?id=1161816734","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161816734?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:22","pubTimestamp":1776943370,"startTime":"0","endTime":"0","summary":"On 23 April 2026, China Medical System Holdings Limited (CMS) announced that China’s National Medical Products Administration (NMPA) has formally accepted the New Drug Application (NDA) for MG-K10...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629835392","title":"China Medical System shareholders approved RMB 0.1366 final dividend per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2629835392","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629835392?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:17","pubTimestamp":1776943074,"startTime":"0","endTime":"0","summary":"China Medical System Holdings held its annual general meeting on April 23, 2026 to vote on shareholder resolutions.Shareholders adopted audited consolidated financial statements and related board and auditor reports for year ended Dec. 31, 2025.Final dividend of RMB 0.1366 per share for 2025 was approved; payment was not confirmed.Deloitte Touche Tohmatsu was reappointed as auditor; engagement terms were authorized but execution was not confirmed.Board received mandates to issue shares, repurchase shares, and extend issuance mandate by amount of any repurchased shares; any transactions were not confirmed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Medical System Holdings Ltd. published the original content used to generate th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL8pT4pp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BMCWC346.EUR","SG9999015978.USD","IE00BYV24P56.USD","LU2488822045.USD","IE00BVYPNP33.GBP","SG9999015986.USD","SG9999004220.SGD","SG9999015945.SGD","SG9999015952.SGD","IE00BGHQDM52.EUR","IE00BVYPNQ40.USD","BK1191","BK1593","00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195581183","title":"CMS Announces NMPA Acceptance of New Drug Application for MG-K10 in Seasonal Allergic Rhinitis","url":"https://stock-news.laohu8.com/highlight/detail?id=1195581183","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195581183?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:16","pubTimestamp":1776943019,"startTime":"0","endTime":"0","summary":"CMS disclosed that the China National Medical Products Administration (NMPA) has accepted the marketing authorization application for its Class 1 innovative drug, MG-K10, targeting seasonal allergic...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BYV24P56.USD","SG9999015945.SGD","IE00B19Z4B17.USD","LU2488822045.USD","IE0031619046.USD","IE00B7SZL793.SGD","SG9999004220.SGD","MG","IPOS","BK1593","SG9999015952.SGD","IE00B66KJ199.SGD","SG9999015986.USD","BK4123","BK1191","IE00BVYPNP33.GBP","00867","IE00BVYPNQ40.USD","SG9999015978.USD","IE00BGHQDM52.EUR","IE00BMCWC346.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629087833","title":"China Medical System says China regulator accepts MG-K10 allergic rhinitis NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2629087833","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629087833?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:15","pubTimestamp":1776942911,"startTime":"0","endTime":"0","summary":"China Medical System said China NMPA accepted new drug application for MG-K10  injection for moderate-to-severe seasonal allergic rhinitis in adults on April 23, 2026.MG-K10 is a long-acting anti-IL-4Rα monoclonal antibody designed for once-every-four-weeks dosing.CMS holds co-development rights in China excluding atopic dermatitis, with exclusive commercialization rights across Greater China and Singapore under a collaboration with Hunan Mabgeek Biotech.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Medical System Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 23, 2026, and is solely responsible for the in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDLLnKSK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","BK1593","IE00BVYPNQ40.USD","IE00BMCWC346.EUR","SG9999015978.USD","00867","SG9999015986.USD","IE00BYV24P56.USD","SG9999015952.SGD","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","SG9999004220.SGD","LU2488822045.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629833960","title":"China Medical System - New Drug Application for Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug Mg-K10 Accepted in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2629833960","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629833960?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:08","pubTimestamp":1776942505,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nFWN4151GQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","BK1593","LU2488822045.USD","SG9999015978.USD","SG9999004220.SGD","SG9999015945.SGD","IE00BYV24P56.USD","SG9999015986.USD","IE00BMCWC346.EUR","SG9999015952.SGD","00867","IE00BVYPNQ40.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131086105","title":"CMS Sets 23 Apr 2026 AGM; Proposes RMB0.1366 Final Dividend, 20% Issue Mandate and 10% Buy-back Authority","url":"https://stock-news.laohu8.com/highlight/detail?id=1131086105","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131086105?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:25","pubTimestamp":1775042720,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited (CMS) has issued a circular convening its 2026 Annual General Meeting (AGM) for 23 April 2026 at 10:00 a.m. in Hong Kong. Key resolutions to be tabled include...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624590359","title":"China Medical System Holdings announces annual general meeting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2624590359","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624590359?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:11","pubTimestamp":1775041888,"startTime":"0","endTime":"0","summary":"China Medical System Holdings will hold annual general meeting in Hong Kong on April 23, 2026.Shareholders will review audited consolidated financial statements for year ended Dec. 31, 2025.Vote scheduled on final dividend of RMB 0.1366 per share.Meeting will consider re-election of Lam Kong as executive director, re-election of Fung Ching Simon as independent non-executive director, reappointment of Deloitte Touche Tohmatsu as auditor.Resolutions include mandates to issue shares up to 20% of shares outstanding, repurchase up to 10%, extend issuance mandate by shares repurchased.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Medical System Holdings Ltd. published the original content used to generate this news brief via IIS, the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL34GVyt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BYV24P56.USD","BK1191","IE00BVYPNP33.GBP","IE00BMCWC346.EUR","SG9999015986.USD","00867","SG9999015945.SGD","SG9999015978.USD","BK1593","LU2488822045.USD","IE00BVYPNQ40.USD","SG9999015952.SGD","IE00BGHQDM52.EUR","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171475693","title":"中国医疗系统 2025 年度业绩：收入达 82.121 亿元，研发投入大幅攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=1171475693","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171475693?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:09","pubTimestamp":1775041792,"startTime":"0","endTime":"0","summary":"中国医疗系统控股有限公司（下称「公司」或「CMS」）公布其截至 2025 年 12 月 31 日止年度业绩与业务进展。报告期内，公司持续推进皮肤科及多领域创新研发，收入与核心业务结构均出现明显变化，并在多项新产品许可及国际市场拓展上取得进展。 在整体财务表现方面，2025 年度公司实现营业收入约 82.121 亿元（2024 年同期为 74.69 亿元），同比增长 9.9%。公司全年毛利约...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624597574","title":"China Medical System publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2624597574","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624597574?lang=en_us&edition=fundamental","pubTime":"2026-04-01 18:57","pubTimestamp":1775041053,"startTime":"0","endTime":"0","summary":"China Medical System annual report for fiscal 2025 flagged return to growth, driven by innovative medicines and exclusive products as volume-based procurement impact eased.Portfolio shift accelerated, with key exclusive or branded products and innovative medicines rising to 59.8% of revenue on a direct-sales basis.Pipeline advanced with 2 new drugs reaching market in early 2026, with 6 marketing applications under review in China to support next growth phase.Group pushed specialty expansion beyond hospitals into retail, digital channels, consumer healthcare, with Dermavon positioned for proposed Hong Kong spin-off listing.International footprint broadened via secondary listing on SGX-ST in July 2025, using Singapore as hub for emerging-market buildout across R&D, manufacturing, commercialization.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated conten","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL3b8JWg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","SG9999004220.SGD","IE00BMCWC346.EUR","IE00BYV24P56.USD","IE00BGHQDM52.EUR","SG9999015945.SGD","IE00BVYPNP33.GBP","SG9999015986.USD","BK1191","LU2488822045.USD","IE00BVYPNQ40.USD","00867","BK1593","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112078432","title":"CMS Affirms Stable Capital Structure in March 2026 Monthly Return; Issued Shares Hold at 2.44 B","url":"https://stock-news.laohu8.com/highlight/detail?id=1112078432","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112078432?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:44","pubTimestamp":1774957485,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited (CMS) submitted its Monthly Return for the period ended 31 March 2026, indicating a static share capital profile during the month. • Authorised share capital...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622007192","title":"China Medical System Holdings (SEHK:867) Valuation After Desidustat Approval And Recent Share Price Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=2622007192","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622007192?lang=en_us&edition=fundamental","pubTime":"2026-03-26 01:13","pubTimestamp":1774458787,"startTime":"0","endTime":"0","summary":"China Medical System Holdings (SEHK:867) has secured Chinese regulatory approval for Desidustat Tablets, an oral treatment for renal anaemia in non dialysis adult chronic kidney disease patients, expanding its presence in the nephrology segment.\nSee our latest analysis for China Medical System Holdings.\nThe share price is at HK$13.27 after a 1 day share price return of 2.47%. However, the 30 day share price return shows a 14.05% decline, which contrasts with an 82.01% 1 year total shareholder...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-holdings-sehk867-valuation-after-desidu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-holdings-sehk867-valuation-after-desidu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BVYPNQ40.USD","SG9999015952.SGD","SG9999004220.SGD","BK1191","IE00BGHQDM52.EUR","IE00BYV24P56.USD","LU2488822045.USD","SG9999015986.USD","SG9999015978.USD","BK1593","IE00BMCWC346.EUR","SG9999015945.SGD","00867","DCF","IE00BVYPNP33.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621758686","title":"China Medical System Wins Desidustat Approval Raising Nephrology Growth Questions","url":"https://stock-news.laohu8.com/highlight/detail?id=2621758686","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621758686?lang=en_us&edition=fundamental","pubTime":"2026-03-20 23:10","pubTimestamp":1774019418,"startTime":"0","endTime":"0","summary":"China Medical System Holdings (SEHK:867) has received marketing approval in China for Desidustat Tablets, an oral treatment for renal anaemia in non dialysis chronic kidney disease patients.\nThe approval adds a new drug to the company’s nephrology portfolio and targets a major unmet medical need in China.\n\nChina Medical System Holdings is drawing fresh attention after this new approval, with the share price at HK$13.49 and a 1 year return of 81.4%. The stock has also seen a 6.1% gain over...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-wins-desidustat-approval-raising-nephro","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-wins-desidustat-approval-raising-nephro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999004220.SGD","SG9999015986.USD","BK1593","IE00BYV24P56.USD","SG9999015945.SGD","BK1191","IE00BVYPNP33.GBP","00867","IE00BVYPNQ40.USD","SG9999015978.USD","SG9999015952.SGD","LU2488822045.USD","IE00BGHQDM52.EUR","IE00BMCWC346.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620574258","title":"China Medical System Holdings SEHK 867 Margin Decline Tests Bullish Growth Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2620574258","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620574258?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:05","pubTimestamp":1773828329,"startTime":"0","endTime":"0","summary":"China Medical System Holdings (SEHK:867) has put fresh numbers on the table for FY 2025, posting first half revenue of C¥4.0b and basic EPS of C¥0.39, alongside trailing twelve month revenue of C¥7.9b and EPS of C¥0.68. The company has seen revenue move from C¥3.6b in the first half of FY 2024 to C¥4.0b in the first half of FY 2025 and trailing revenue shift from C¥7.5b to C¥7.9b, with basic EPS across reported halves ranging between C¥0.29 and C¥0.39. For you as an investor, the key question...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-holdings-sehk-867-margin-decline-tests","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/china-medical-system-holdings-sehk-867-margin-decline-tests","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["00867","IE00BYV24P56.USD","BLSX","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","SG9999015952.SGD","LU2488822045.USD","BLSG","IE00BVYPNQ40.USD","IE00BMCWC346.EUR","SG9999015945.SGD","SG9999015986.USD","BK1593","SG9999015978.USD","SG9999004220.SGD","BK4112","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144733107","title":"Stock Track | CMS Soars 5.09% Intraday After Analyst Upgrade and Target Price Hike","url":"https://stock-news.laohu8.com/highlight/detail?id=1144733107","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144733107?lang=en_us&edition=fundamental","pubTime":"2026-03-18 13:45","pubTimestamp":1773812717,"startTime":"0","endTime":"0","summary":"CMS's stock price surged 5.09% during intraday trading on Wednesday, following a bullish research report from a major brokerage.The sharp rise came after CICC maintained its Outperform rating on CMS...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117291615","title":"Analysts Maintain Outperform Rating on CMS, Raise Target Price to HK$17.50","url":"https://stock-news.laohu8.com/highlight/detail?id=1117291615","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117291615?lang=en_us&edition=fundamental","pubTime":"2026-03-18 11:02","pubTimestamp":1773802959,"startTime":"0","endTime":"0","summary":"CICC has released a research report stating that, considering the contribution from new product sales, it has raised its adjusted net profit forecast for CMS (00867) for 2026/2027 by 6%/9% to RMB...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","IE00BYV24P56.USD","IE00BGHQDM52.EUR","IE00BMCWC346.EUR","IE00BVYPNQ40.USD","BK1593","SG9999015945.SGD","SG9999015986.USD","LU2488822045.USD","SG9999004220.SGD","00867","IE00BVYPNP33.GBP","SG9999015952.SGD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109641295","title":"CMS (00867) 2025 Net Profit Normalised Up 3.6%; Turnover Rises 9.9% to RMB 8.21 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1109641295","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109641295?lang=en_us&edition=fundamental","pubTime":"2026-03-17 17:23","pubTimestamp":1773739430,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited (CMS, 00867.HK; 8A8.SGX) released its audited results for the year ended 31 December 2025, marking the first set of annual results since its secondary listing in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cms.net.cn","stockEarnings":[{"period":"1week","weight":-0.0402},{"period":"1month","weight":-0.2029},{"period":"3month","weight":-0.2656},{"period":"6month","weight":-0.1512},{"period":"1year","weight":0.2422},{"period":"ytd","weight":-0.138}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0306},{"period":"6month","weight":0.0153},{"period":"1year","weight":0.0876},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and sales of drugs. The Company's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The Company distributes its products within domestic market and to overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.010995},{"month":2,"riseRate":0.6,"avgChangeRate":0.034643},{"month":3,"riseRate":0.4375,"avgChangeRate":-0.007421},{"month":4,"riseRate":0.5,"avgChangeRate":0.025609},{"month":5,"riseRate":0.4375,"avgChangeRate":0.001923},{"month":6,"riseRate":0.666667,"avgChangeRate":0.005928},{"month":7,"riseRate":0.533333,"avgChangeRate":-0.008681},{"month":8,"riseRate":0.4,"avgChangeRate":0.021864},{"month":9,"riseRate":0.466667,"avgChangeRate":0.005632},{"month":10,"riseRate":0.5,"avgChangeRate":0.008421},{"month":11,"riseRate":0.5625,"avgChangeRate":0.05425},{"month":12,"riseRate":0.5625,"avgChangeRate":0.034371}],"exchange":"SEHK","name":"CMS","nameEN":"CMS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CMS(00867),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CMS(00867) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CMS,00867,CMS股票,CMS股票老虎,CMS股票老虎国际,CMS行情,CMS股票行情,CMS股价,CMS股市,CMS股票价格,CMS股票交易,CMS股票购买,CMS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CMS(00867),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CMS(00867) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}